In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells

Chronic myelogenous leukemia (CML) is a malignant hematological disorder mainly caused by the Bcr-Abl tyrosine kinase. While Bcr-Abl inhibitors including Imatinib showed antitumor efficacy on many CML patients, resistance was frequently reported in recent years. Therefore, novel drugs for CML are st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qianxiang, Chen, Yali, Chen, Xi, Zhao, Wennan, Zhong, Yuxu, Wang, Ran, Jin, Meihua, Qiu, Yuling, Kong, Dexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870707/
https://www.ncbi.nlm.nih.gov/pubmed/27194941
http://dx.doi.org/10.7150/ijbs.14878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870707/
https://www.ncbi.nlm.nih.gov/pubmed/27194941
http://dx.doi.org/10.7150/ijbs.14878

Ejemplares similares